Barry J. Moze
2018
Compensation breakdown
| Non-Equity Incentive Plan | $579,989 |
|---|---|
| Salary | $590,400 |
| Stock Awards | $1,527,062 |
| Other | $35,114 |
| Total | $2,732,565 |
Moze received $1.5M in stock awards, accounting for 56% of the total pay in 2018.
Moze also received $580K in non-equity incentive plan, $590.4K in salary and $35.1K in other compensation.
Rankings
In 2018, Barry J. Moze's compensation ranked 4,279th out of 14,244 executives tracked by ExecPay. In other words, Moze earned more than 70.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,279 out of 14,244 | 70th |
Division Manufacturing | 1,586 out of 5,765 | 73rd |
Major group Chemicals And Allied Products | 567 out of 2,128 | 73rd |
Industry group Drugs | 474 out of 1,817 | 74th |
Industry Pharmaceutical Preparations | 367 out of 1,391 | 74th |
Pay ratio
| Barry J. Moze's Pay | $2,732,565 |
|---|---|
| Median Employee's Pay | $207,196 |
| Pay Ratio | 13to 1 |
In 2018, the annual total compensation of Barry J. Moze was $2,732,565.
The annual total compensation of the median employee at Horizon Pharma was $207,196.
The ratio of Barry J. Moze's pay to the pay of median employee was therefore 13 to one.
Moze's colleagues
We found six more compensation records of executives who worked with Barry J. Moze at Horizon Pharma in 2018.
2018
Timothy Walbert
Horizon Pharma
Chief Executive Officer
2018
Paul Hoelscher
Horizon Pharma
Chief Financial Officer
2018
Robert Carey
Horizon Pharma
Executive Vice President, Chief Business Officer
2018
Shao-Lee Lin
Horizon Pharma
Chief Scientific Officer
2018
Jeffrey FACP
Horizon Pharma
Chief Medical Officer
2018
Vikram Karnani
Horizon Pharma
Executive Vice President, Chief Commercial Officer
News
March 17, 2022
March 17, 2021
March 18, 2020
April 8, 2019